scholarly journals Pulmonary Actinomycosis Imitating Lung Cancer on18F-FDG PET/CT: A Case Report and Literature Review

2015 ◽  
Vol 16 (6) ◽  
pp. 1262 ◽  
Author(s):  
Lin Qiu ◽  
Lianjun Lan ◽  
Yue Feng ◽  
Zhanwen Huang ◽  
Yue Chen
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Literature Review ◽  
Fdg Pet ◽  
Pulmonary Actinomycosis ◽  
Pet Ct ◽  
Fdg Pet Ct

scholarly journals Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review

2017 ◽  
Vol 23 (6) ◽  
pp. 908-912 ◽  
Author(s):  
Elda Righi ◽  
Alessia Carnelutti ◽  
Daniele Muser ◽  
Francesco Zaja ◽  
Elisa Lucchini ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Successful Treatment ◽  
Fdg Pet ◽  
Neutropenic Patient ◽  
Patient Case ◽  
Pet Ct ◽  
Fdg Pet Ct

scholarly journals Benign metastasizing leiomyoma and 18-FDG-PET/CT: A case report and literature review

2017 ◽  
Vol 14 (3) ◽  
pp. 3641-3646 ◽  
Author(s):  
Yusuke Sawai ◽  
Toshiki Shimizu ◽  
Yuta Yamanaka ◽  
Maiko Niki ◽  
Shosaku Nomura
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Fdg Pet ◽  
Benign Metastasizing Leiomyoma ◽  
Pet Ct ◽  
Metastasizing Leiomyoma ◽  
Fdg Pet Ct

scholarly journals 18F-FDG PET/CT in Patients with Nodular Pulmonary Amyloidosis: Case Report and Literature Review

2014 ◽  
Vol 7 (3) ◽  
pp. 789-798 ◽  
Author(s):  
Xiao-Qing Quan ◽  
Tie-Jun Yin ◽  
Cun-Tai Zhang ◽  
Jian Liu ◽  
Li-Fen Qiao ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Fdg Pet ◽  
Pet Ct ◽  
18F Fdg ◽  
Pulmonary Amyloidosis ◽  
Fdg Pet Ct

scholarly journals Paraneoplastic Cerebellar Degeneration as Initial Presentation of Papillary Carcinoma of the Fallopian Tube: Evaluation and Usefulness of 18F-FDG PET-CT. Case Report and Literature Review

2012 ◽  
Vol 47 (1) ◽  
pp. 55-60 ◽  
Author(s):  
Nayelli Ortega López ◽  
Digna Pachuca González ◽  
José Alfonso Rumoroso García ◽  
Juan Carlos García Reyna ◽  
Luis Felipe Alva López
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Papillary Carcinoma ◽  
Fallopian Tube ◽  
Fdg Pet ◽  
Cerebellar Degeneration ◽  
Initial Presentation ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

scholarly journals Case Report: Two Rare Cases of Complete Metabolic Response to Crizotinib in Patients With Rearranged ROS1 and ALK Metastatic Non-small Lung Cancer

2021 ◽  
Vol 8 ◽  
Author(s):  
Karim Amrane ◽  
Luca Campedel ◽  
Coline Le Meur ◽  
Ronan Abgral ◽  
Dris Kharroubi ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Case Report ◽  
Fdg Pet ◽  
Kinase Inhibitor ◽  
Metabolic Response ◽  
Complete Metabolic Response ◽  
Anaplastic Lymphoma ◽  
Pet Ct ◽  
Fdg Pet Ct

Crizotinib is a tyrosine kinase inhibitor (TKI) indicated in first-line treatment of rearranged c-ros oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK) metastatic non-small-cell lung cancer (NSCLC). However, the common response reported after treatment is partial and few complete responses have been reported in PROFILE studies with computed tomography (CT) evaluation. To date, only one case report of complete metabolic response on 2-deoxy-2-[18F] fluoro-D-glucose positron emission tomography-computed tomography (18F-FDG-PET/CT) was published, reporting on a patient with ROS1 rearranged NSCLC. We highlighted the 18F-FDG-PET/CT useful approach for therapeutic assessment of TKI in metastatic mutated NSCLC reporting two complete metabolic responses in patients treated with crizotinib for a rearranged ROS1 and a metastatic ALK NSCLC.

Sign in / Sign up

Export Citation Format

Share Document